SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 82 filers reported holding SEELOS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $24,023 | +70.1% | 20,103 | -1.6% | 0.00% | – |
| Q1 2023 | $14,127 | -1.4% | 20,438 | -3.1% | 0.00% | – |
| Q4 2022 | $14,322 | -42.7% | 21,093 | -12.1% | 0.00% | – |
| Q3 2022 | $25,000 | -75.7% | 24,003 | -84.1% | 0.00% | – |
| Q2 2022 | $103,000 | -6.4% | 151,335 | +15.0% | 0.00% | – |
| Q1 2022 | $110,000 | -56.9% | 131,609 | -16.1% | 0.00% | – |
| Q4 2021 | $255,000 | +8.5% | 156,833 | +60.6% | 0.00% | – |
| Q3 2021 | $235,000 | -48.1% | 97,645 | -43.1% | 0.00% | – |
| Q2 2021 | $453,000 | -58.5% | 171,595 | -21.5% | 0.00% | – |
| Q1 2021 | $1,091,000 | +1002.0% | 218,611 | +250.1% | 0.00% | – |
| Q4 2020 | $99,000 | – | 62,441 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 508,000 | $249,000 | 0.10% |
| 1492 Capital Management LLC | 150,000 | $74,000 | 0.09% |
| Uniplan Investment Counsel, Inc. | 2,069,121 | $1,014,000 | 0.08% |
| ARDSLEY ADVISORY PARTNERS LP | 70,000 | $34,000 | 0.01% |
| Spark Investment Management LLC | 35,210 | $17,000 | 0.01% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 191,000 | $94,000 | 0.00% |
| WealthPLAN Partners, LLC | 20,000 | $15,000 | 0.00% |
| Procyon Advisors, LLC | 2,500 | $1,000 | 0.00% |
| Renaissance Technologies | 1,078,379 | $529,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |